Renalytix shares fall 25% as revenues miss expectations
Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes
MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities
Renalytix Plc (RNLXY) Q2 2025 Earnings Call Transcript
Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025
Warning: RNLXY is at high risk of performing badly
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
